Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial

“Association of glucose concentrations at hospital discharge with readmissions and mortality: A nationwide cohort study.”

(2019) Elias K Spanakis et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Switching to insulin glargine 300 units/mL in real‐world older patients with type 2 diabetes (DELIVER 3)

(2019) Timothy S. Bailey et al.   DIABETES OBESITY & METABOLISM

Real-world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes using basal insulin

(2018) Fang Liz Zhou et al.   DIABETES OBESITY & METABOLISM

Basal–Bolus Insulin Therapy with Gla-300 During Hospitalization Reduces Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study

(2018) Fumitaka Okajima et al.   Diabetes Therapy

Basal–Bolus Insulin Therapy with Gla-300 During Hospitalization Reduces Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study

(2018) Fumitaka Okajima et al.   Diabetes Therapy

More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial

(2018) Julio Rosenstock et al.   DIABETES CARE

Rendimiento de los indicadores tras la implementación del Documento de consenso español para el control de la hiperglucemia en el hospital y al alta

(2018) A. Pérez et al.   REVISTA CLINICA ESPANOLA

15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2019

(2018)   DIABETES CARE

Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2018) Melanie J. Davies et al.   DIABETOLOGIA

Análisis de las hospitalizaciones por enfermedad cardiovascular en población diabética en España

(2018) A. Zapatero-Gaviria et al.   REVISTA CLINICA ESPANOLA

Clinical inertia to insulin initiation and intensification in the UK: A focused literature review

(2017) Kamlesh Khunti et al.   Primary Care Diabetes

Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin

(2016) K. Khunti et al.   DIABETES OBESITY & METABOLISM

Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 Diabetes

(2016) Matthew C. Riddle et al.   Diabetes Technology & Therapeutics

Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes

(2016) Lisa Elliott et al.   Diabetes Therapy

Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes

(2016) Lisa Elliott et al.   Diabetes Therapy

Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes

(2015) Virginia Bellido et al.   DIABETES CARE

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension

(2015) M. C. Riddle et al.   DIABETES OBESITY & METABOLISM

Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extensi

(2015) H. Yki-Järvinen et al.   DIABETES OBESITY & METABOLISM

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)

(2015) G. B. Bolli et al.   DIABETES OBESITY & METABOLISM

Hospital Discharge Algorithm Based on Admission HbA1cfor the Management of Patients With Type 2 Diabetes

(2014) Guillermo E. Umpierrez et al.   DIABETES CARE

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2014) Silvio E. Inzucchi et al.   DIABETES CARE

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)

(2014) Matthew C. Riddle et al.   DIABETES CARE

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2)

(2014) Hannele Yki-Järvinen et al.   DIABETES CARE

New Insulin Glargine 300 units{middle dot}mL-1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 units{middle dot}mL-1

(2014) R. H. A. Becker et al.   DIABETES CARE

Efficacy and feasibility of basal-bolus insulin regimens and a discharge-strategy in hospitalised patients with type 2 diabetes - the HOSMIDIA study

(2014) A. Pérez et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes: Basal Plus Trial

(2013) G. E. Umpierrez et al.   DIABETES CARE

Impact of inpatient diabetes management, education, and improved discharge transition on glycemic control 12 months after discharge

(2012) Deborah J. Wexler et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Clinical Inertia of Discharge Planning among Patients with Poorly Controlled Diabetes Mellitus

(2012) Michelle L. Griffith et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline

(2012) Guillermo E. Umpierrez et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)

(2011) G. E. Umpierrez et al.   DIABETES CARE

Discontinuation of Antihyperglycemic Therapy and Clinical Outcomes After Acute Myocardial Infarction in Older Patients With Diabetes

(2010) Kasia J. Lipska et al.  

Management of diabetes and hyperglycemia in the hospital: A practical guide to subcutaneous insulin use in the non-critically ill, adult patient

(2010) David Wesorick et al.   Journal of Hospital Medicine

American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control

(2009) E. S. Moghissi et al.   DIABETES CARE

Barriers to insulin initiation and intensification and how to overcome them

(2009) T. Kunt et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Inpatient glucose control: a glycemic survey of 126 U.S. hospitals

(2009) Curtiss B. Cook et al.   Journal of Hospital Medicine

Tratamiento de la hiperglucemia en el hospital

(2009) Antonio Pérez Pérez et al.   MEDICINA CLINICA

Comparison of Inpatient Insulin Regimens with Detemir plus AspartVersusNeutral Protamine Hagedorn plus Regular in Medical Patients with Type 2 Diabetes

(2008) Guillermo E. Umpierrez et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM